|
2023
|
Invention
|
Oxabicycloheptanes and oxabicycloheptenes for treating refractory cancers. The present invention ... |
|
|
Invention
|
Methods for treating soft tissue sarcoma.
The invention relates to a pharmaceutical composition ... |
|
|
Invention
|
Compositions and methods for treating cancer or preventing, inhibiting or reducing risk of metast... |
|
2022
|
Invention
|
Oxabicycloheptanes for treatment of small cell lung cancer.
The present invention provides a met... |
|
|
Invention
|
Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitor.
This inventio... |
|
|
Invention
|
Oxabicycloheptane prodrugs. The present invention provides a compound having the structure:
|
|
2021
|
Invention
|
Oxabicycloheptanes for treatment of small cell lung cancer. The present invention provides a meth... |
|
2019
|
Invention
|
Formulations of oxabicycloheptanes and oxabicycloheptenes. The invention relates to a pharmaceuti... |
|
|
Invention
|
Oxabicycloheptanes for enhancing car t cell function.
The present invention provides a method of... |
|
|
Invention
|
Oxabicycloheptanes for enhancing car t cell function. The present invention provides a method of ... |
|
2018
|
Invention
|
Oxabicycloheptanes for treatment of secondary acute myeloid leukemia.
The present invention rela... |
|
|
Invention
|
Oxabicycloheptanes for treatment of secondary acute myeloid leukemia. The present invention relat... |
|
|
Invention
|
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes. A method of increasing t... |
|
|
Invention
|
Protein phosphatase 2a inhibitors for treating myelodysplastic syndromes. Disclosed are methods f... |
|
|
Invention
|
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use. This invention provides com... |
|
2017
|
Invention
|
Oxabicycloheptanes for modulation of immune response. The present invention provides a method of ... |
|
|
Invention
|
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders. A... |
|
|
Invention
|
Sanguinarine analog pp2c inhibitors for cancer treatment.
Sanguinarine analogs as PP2C inhibitor... |
|
|
Invention
|
Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitor. This invention... |
|
2016
|
Invention
|
Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase.
Disclosed herein... |
|
|
Invention
|
Oxabicycloheptane prodrugs. The present invention provides a compound having the structure : Form... |
|
2015
|
Invention
|
Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxyli... |
|
|
Invention
|
Human dosing of phosphatase inhibitor.
The present invention provides a method of inhibiting pro... |
|
|
Invention
|
Human dosing of phosphatase inhibitor. The present invention provides a method of inhibiting prot... |
|
|
Invention
|
Oxabicycloheptanes and oxabicycloheptenes for the treatment of ovarian cancer.
A method of treat... |
|
|
Invention
|
Oxabicycloheptanes and oxabicycloheptenes for the treatment of ovarian cancer. A method of treati... |
|
2014
|
Invention
|
Protein phosphatase inhibitors that cross the blood brain barrier.
The present invention provide... |
|
|
Invention
|
Hdac inhibitors for the treatment of traumatic brain injury.
The present invention provides a me... |
|
2013
|
Invention
|
Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury.
A method of r... |
